Figure 2
From: Early diagnostic value of survivin and its alternative splice variants in breast cancer
Exosome level and exosomal contents from patient sera. (A) Acetylcholinesterase Activity Assay: exosomes quantity was shown in the graph from sera of breast cancer patients (n = 40) with controls (n = 10) (**p < 0.01) (BC, breast cancer). (B) Western blot analysis of all exosomal Survivin, Survivin-2B, Survivin-∆Ex3, and LAMP1 from breast cancer patients sera (n = 40). (C) Densitometric analysis of Survivin, Survivin-2B, Survivin-∆Ex3, and LAMP1 expression was performed. A ratio of each Survivin variant to LAMP1 was calculated and depicted in the graph (error bar = mean +/- SD).